114 related articles for article (PubMed ID: 4223070)
1. Controlled clinical trial of "Atromid" (androsterone with ethyl-p-chlorophenoxy-isobutyrate) and "Persantin" (dipyridamole) in cases of myocardial infarction.
Teik KO; Poh FW; Fun CS; Mong BC
Med J Malaya; 1966 Mar; 20(3):186-204. PubMed ID: 4223070
[No Abstract] [Full Text] [Related]
2. Treatment of hyperlipidemia with the ethyl-ester of chlorophenoxyisobutyrate and androsterone.
Schatz IJ
Henry Ford Hosp Med J; 1965 Dec; 13(4):447-56. PubMed ID: 5325188
[No Abstract] [Full Text] [Related]
3. A comparison of platelet stickiness tests during an atromid-S trial.
O'Brien JR; Heywood JB
Thromb Diath Haemorrh; 1966 Dec; 16(3):768-77. PubMed ID: 5996687
[No Abstract] [Full Text] [Related]
4. A controlled trial of Atromid therapy in exudative diabetic retinopathy.
Cullen JF; Ireland JT; Oliver MF
Trans Ophthalmol Soc U K (1962); 1964; 84():281-95. PubMed ID: 5227423
[No Abstract] [Full Text] [Related]
5. [Clinical experimentation with CPIB (with or without androsterone) in the treatment of hyperlipemia. Apropos of 35 cases].
Warembourg H; Jaillard J
Lille Med; 1965 Apr; 10(4):431-6. PubMed ID: 5318637
[No Abstract] [Full Text] [Related]
6. [Results of atromid or CPIB treatment with and without androsterone in hyperlipemia (110 therapeutic trials in 2 years)].
de Gennes JL; Maunand B; Salmon ; Laudat P; Truffert J
Bull Mem Soc Med Hop Paris; 1965 Apr; 116(8):759-84. PubMed ID: 5834264
[No Abstract] [Full Text] [Related]
7. Clinical trial with ethyl-a-p-chlorophenoxyisobutyrate (Atromid-S) with special reference to white blood cell counts.
Engström J
Acta Med Scand; 1966 Nov; 180(5):519-31. PubMed ID: 5332263
[No Abstract] [Full Text] [Related]
8. A three-year trial of atromid therapy in exudative diabetic retinopathy.
Duncan LJ; Cullen JF; Ireland JT; Nolan J; Clarke BF; Oliver MF
Diabetes; 1968 Jul; 17(7):458-67. PubMed ID: 4875170
[No Abstract] [Full Text] [Related]
9. Farewell to androsterone in atromid.
Drug Ther Bull; 1966 Jan; 4(2):8. PubMed ID: 5905897
[No Abstract] [Full Text] [Related]
10. [A case of essential hyperlipemia treated with atromid].
Baczko A; Ciświcka-Sznajderman M; Jakubowicz K; Sznajderman M
Kardiol Pol; 1965; 8(2):135-41. PubMed ID: 5836657
[No Abstract] [Full Text] [Related]
11. [Experience with 110 medium-length therapeutic trials of ethyl chlorophenoxyisobutyrate with or without androsterone in various types of idiopathic hyperlipidemia].
De Gennes JL; Maunand B; Salmon D; Laudat P; Truffert J
Rev Atheroscler (Paris); 1966; 8(1):27-52. PubMed ID: 5961027
[No Abstract] [Full Text] [Related]
12. [Effect of administration of hydrocortisone and dipyridamole (persantin) on plasma levels of prostaglandin E1 and F2 alpha in patients with myocardial infarction].
Miturzyńska-Stryjecka H
Wiad Lek; 1987 Nov; 40(21):1441-6. PubMed ID: 3482754
[No Abstract] [Full Text] [Related]
13. [Clinical and electrocardiographical observations on the evolution of myocardial infarct treated with a derivative of pyrimido-pyrimidine (Persantin) in intravenous infusion].
Martinetti L; Balzano I
Minerva Med; 1966 Aug; 57(63):2699-710. PubMed ID: 5911867
[No Abstract] [Full Text] [Related]
14. [Antiaggregant effect of slow-release dipyridamole in acute myocardial infarct].
Scabbia E; Bellocci F; Montenero AS; Albanese S; Coppola E; Cudillo L
Minerva Cardioangiol; 1988; 36(7-8):347-50. PubMed ID: 2974931
[No Abstract] [Full Text] [Related]
15. [Long-term treatment of previously therapy-resistant cases of primary hypertriglyceridemia of the adult with ethyl-p-chlorophenoxyisobutyrate].
Braunsteiner H; Herbst M; Sandhofer F; Sailer S
Dtsch Med Wochenschr; 1967 Dec; 92(50):2302-8. PubMed ID: 6075896
[No Abstract] [Full Text] [Related]
16. Atromid and platelet adhesiveness in multiple sclerosis.
Millac P; Caspary EA; Prineas J
J Atheroscler Res; 1967; 7(3):397-400. PubMed ID: 5340971
[No Abstract] [Full Text] [Related]
17. [Atromid].
Borchgrevink CF
Tidsskr Nor Laegeforen; 1967 Mar; 87(5):334. PubMed ID: 6039533
[No Abstract] [Full Text] [Related]
18. [Effect of persantin on selected platelet functions in myocardial infarct].
Markiewicz M; Kowalewski J; Florkiewicz H; Pluta A; Koziara Z; Szponar M; Dmosyńska A
Pol Tyg Lek; 1980 Sep; 35(35):1343-5. PubMed ID: 7433215
[No Abstract] [Full Text] [Related]
19. [Observations on the treatment of myocardial infarct with 2-6-bis-(diethanolamino)-4,8-dipiperidino-pyrimido-5,4-d)-pyrimidine (Persantin) in slow venous perfusion].
Marangoni R; Brera V; Ferrari A
Minerva Cardioangiol; 1966 Jun; 14(6):373-9. PubMed ID: 5917541
[No Abstract] [Full Text] [Related]
20. [Effect of Atromid on blood lipids in patients with hyperlipemia].
Baranova LV
Ter Arkh; 1968 Mar; 40(3):15-20. PubMed ID: 4875984
[No Abstract] [Full Text] [Related]
[Next] [New Search]
